Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunological differences between colorectal cancer and normal mucosa uncover a prognostically relevant immune cell profile
Katharina Strasser, Hanna Birnleitner, Andrea Beer, et al.
OncoImmunology (2018) Vol. 8, Iss. 2, pp. e1537693-e1537693
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
Émilie Picard, Chris P. Verschoor, W Kitonyi Grace, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 403
Calreticulin and cancer
Jitka Fučíková, Radek Špíšek, Guido Kroemer, et al.
Cell Research (2020) Vol. 31, Iss. 1, pp. 5-16
Open Access | Times Cited: 286
Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer
Penglei Ge, Weiwei Wang, Lin Li, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109228-109228
Open Access | Times Cited: 192
The role of neutrophil death in chronic inflammation and cancer
Christine Brostjan, Rudolf Oehler
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 128
Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages
Mira Stadler, Karoline Pudelko, Alexander Biermeier, et al.
Cancer Letters (2021) Vol. 520, pp. 184-200
Open Access | Times Cited: 65
DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer
Qi Zou, Xiaolin Wang, Donglin Ren, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 9, pp. e002671-e002671
Open Access | Times Cited: 59
Tumour cell apoptosis modulates the colorectal cancer immune microenvironment via interleukin-8-dependent neutrophil recruitment
Vanessa Schimek, Katharina Strasser, Andrea Beer, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 47
CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer
Yuanyi Yue, Qiang Zhang, Zhengrong Sun
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 41
An update on colorectal cancer microenvironment, epigenetic and immunotherapy
Ketao Jin, Chengcheng Ren, Yuyao Liu, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107041-107041
Closed Access | Times Cited: 69
Relevance of Regulatory T Cells during Colorectal Cancer Development
Jonadab E. Olguín, Itzel Medina-Andrade, Tonathiu Rodríguez, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1888-1888
Open Access | Times Cited: 47
Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression
Natalie Walterskirchen, Catharina Müller, Cristiano Ramos, et al.
Cancer Letters (2022) Vol. 540, pp. 215737-215737
Open Access | Times Cited: 23
Tumour-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signalling.
Niamh Leonard, Shania M. Corry, Eileen Reidy, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110701-110701
Open Access | Times Cited: 5
Radiotherapy as a Backbone for Novel Concepts in Cancer Immunotherapy
Julijan Kabiljo, Felix Harpain, Sebastian Carotta, et al.
Cancers (2019) Vol. 12, Iss. 1, pp. 79-79
Open Access | Times Cited: 39
Radiomic Immunophenotyping of GSEA-Assessed Immunophenotypes of Glioblastoma and Its Implications for Prognosis: A Feasibility Study
Justin Bo‐Kai Hsu, Gilbert Aaron Lee, Tzu‐Hao Chang, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 3039-3039
Open Access | Times Cited: 38
The TGF‐b/SOX4 axis and ROS‐driven autophagy co‐mediate CD39 expression in regulatory T‐cells
Marlene C. Gerner, Liesa S. Ziegler, Ralf Schmidt, et al.
The FASEB Journal (2020) Vol. 34, Iss. 6, pp. 8367-8384
Open Access | Times Cited: 34
The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis
Zhenwei Yang, Mengna Zhang, Ruyi Peng, et al.
International Journal of Colorectal Disease (2020) Vol. 35, Iss. 9, pp. 1651-1661
Closed Access | Times Cited: 34
Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer
Fanny Andric, Ala Al-Fairouzi, Yvonne Wettergren, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1457-1457
Open Access | Times Cited: 13
The Prognostic Value of CD206 in Solid Malignancies: A Systematic Review and Meta-Analysis
Jens Debacker, Odrade Gondry, Tony Lahoutte, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3422-3422
Open Access | Times Cited: 25
Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
Lifeng Hu, Huanrong Lan, Dong Huang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 25
In vitro 3D modeling of colorectal cancer: the pivotal role of the extracellular matrix, stroma and immune modulation
Veroniaina Hanitrarimalala, Zdenka Prgomet, My Hedhammar, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Colorectal Cancer and Purinergic Signalling: An Overview
Gabriela Gonçalves Roliano, Juliana H. Azambuja, Veronica Brunetto, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4887-4887
Open Access | Times Cited: 13
Transcriptomic Analyses of the Adenoma-Carcinoma Sequence Identify Hallmarks Associated With the Onset of Colorectal Cancer
Hong Qin, Bing Li, Xiumei Cai, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 17
A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression
Cheng Wang, Minghao Zhang, Shunyao Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4819-4831
Open Access | Times Cited: 2
Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations
Louis Szeponik, Filip Ahlmanner, Patrik Sundström, et al.
BMC Immunology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Stromal Cells Promote Matrix Deposition, Remodelling and an Immunosuppressive Tumour Microenvironment in a 3D Model of Colon Cancer
Niamh Leonard, Eileen Reidy, Kerry Thompson, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5998-5998
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top